We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lack of Incentives, Poor Diagnoses Limit Orphan Drug Access in China, India
Lack of Incentives, Poor Diagnoses Limit Orphan Drug Access in China, India
May 10, 2012
Patients with rare diseases in rural China and India are finding it increasingly difficult to obtain necessary medications, and both countries need to find ways to increase access to orphan drugs, experts say.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor